期刊文献+

Survivin在肝细胞癌中的表达及临床意义

Clinical significance of survivin expression in hepatocellular carcinoma
原文传递
导出
摘要 目的研究肝细胞癌(HCC)中Survivin的表达及其与临床指标的关系。方法应用免疫组织化学SP法检测HCC组织及相应癌旁组织Survivin蛋白的表达,TUNEL法检测细胞凋亡指数(AI)。结果 75%的肝癌组织表达Survivin蛋白,而癌旁及正常肝癌组织内均阴性表达。阳性表达率与肝内转移(42.9%和92.3%)、门静脉癌栓形成(47.1%和95.7%)及肿瘤大小(89.3%和47.1%)有关;30例Survivin表达阳性癌组织的AI为(1.558±0.628)%,显著低于Survivin表达阴性癌组织(4.738±0.954)%,(P<0.05)。结论 Survivin可能通过对凋亡的抑制而参与肝癌发生、发展。 Objective To investigate the role of survivin protein expression in the pathogenesis of hepatocellular carcinoma(HCC).Methods Fourty histologically verified HCC specimens and their neighboring noncancerous tissues were obtained.Immunohistochemistry was used to detect protein expressions of survivin and apoptosis index was determined by TUNEL.Results Survivin protein expression was detected in 30 of 40 (75%)cases.By conparison,no expression of survivin in corresponding tissues was detected.The positive rate of survivin expression correlated with intrahepatic metastasis,portal vein cancer emboli and cancer diameter.Conclusion The optional expression of Survivin have a close correlation to the tumor macastasis and vascular infiltration.Survivin expression may play an important part in HCC,which offer a wide prospective for clinical application in the primitive prognosis of hepatic-carcinoma.
作者 刘超 蔡建平
出处 《慢性病学杂志》 2010年第8期844-845,共2页 Chronic Pathematology Journal
关键词 微管相关蛋白质类/代谢 肿瘤蛋白质类/代谢 肝细胞/代谢 Microtubule-Associated Proteins/metabolism Neoplasm Proteins/metabolism Carcinoma Hepatocellular/metabolism
  • 相关文献

参考文献2

二级参考文献15

  • 1Schiiter C, Wohelen D, Berg G. Molecular coleing of the cell proliferation associated unclear antigen difined by antibody Ki-67: a unique gene enconding for new PEST position. J Cell Biol,1993,123:513-515.
  • 2Ambrosini G, Adida C, Altieri DC, et al. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med,1997,3:917-921.
  • 3Pich A, Ponti R, Valente G, et al. MIB-1,Ki-67 and PCNA scores and DNA flow cycometry in intermediate grate malignant lymphomas. J Clin Pathol,1994,47:18-22.
  • 4Ito T, Shiraki K, Sugimoto K, et al. Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology,2000,31:1080-1085.
  • 5Desoize B. Anticancer drug resisitance and inhibition of apoptosis. Anticancer Res,1994,14:2291-2294.
  • 6Palissor V, Trussardi A, Gorisse MC, et al. Factors contributing to the resistance to apoptosis induced by topoisomerase Ⅰ inhibitors in Vincristine resistant cells. Adv Exp Med Biol,1999,457:355-363.
  • 7lseki K, Tatsuata M, Uehara H, et al. Inhibition of angiogenesis as a mechanism for inhibition by 1α-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 of colon carcinogenesis induced by azoxymethane in Wistar rat. Int J Cancer, 1999, 81:730~ 733.
  • 8Ambrosini G,Adida C ,Altieri DC. A novel anti2apoptosis gene survivin, expressed in cancer and lymphoma. Nat Med.1997, 3 :917-921.
  • 9Shankar SL, Mani S, O'Guin KN, et al. Survivin inhibition induces human neural tumor cell death through caspase2independent and dependent pathways. J Neurochem, 2001,79: 426- 436.
  • 10Nicholson DW, Ali A, Thomberry NA, et al. Identification and inhibition of the ICE/CED3 protease necessary for mammalian apoptosis. Nature, 1995, 376:37-43.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部